SEC Form 4 · accession 0000899243-19-001139

MedEquities Realty Trust, Inc. · MRT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

BlueMountain Capital Management, LLC

Director

Period of report

Jan 10, 2019

Accepted (ET)

Jan 14, 2019 · 5:32 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001616314

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2,F3	Jan 10, 2019	S	50,000	$10.45	D	1,647,716	I	Footnotes
Common Stock^F1,F2,F3	Jan 10, 2019	S	10,000	$10.50	D	1,637,716	I	Footnotes
Common Stock^F1,F2,F3	Jan 10, 2019	S	25,000	$10.53	D	1,612,716	I	Footnotes
Common Stock^F1,F2,F3	Jan 10, 2019	S	40,000	$10.62	D	1,572,716	I	Footnotes
Common Stock^F1,F2,F3	Jan 10, 2019	S	25,000	$10.57	D	1,547,716	I	Footnotes
Common Stock^F1,F2,F3	Jan 10, 2019	S	25,000	$10.55	D	1,522,716	I	Footnotes
Common Stock^F1,F2,F4	Jan 11, 2019	S	60,000	$10.61	D	1,462,716	I	Footnotes
Common Stock^F1,F2,F4	Jan 11, 2019	S	20,000	$10.60	D	1,442,716	I	Footnotes

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

F1The filing of this Form 4 shall not be construed as an admission that BlueMountain Capital Management, LLC ("BMCM") is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any of the shares of Common Stock, par value $0.01 per share (the "Common Stock"), of MedEquities Realty Trust, Inc. (the "Issuer"). Pursuant to Rule 16a-1(a)(4) of the Exchange Act, BMCM disclaims such beneficial ownership, except to the extent of its pecuniary interest.
F2BMCM is the investment manager of Blue Mountain Credit Alternatives Master Fund L.P. ("BMCA"), BlueMountain Guadalupe Peak Fund L.P. ("BMGP"), BlueMountain Credit Opportunities Master Fund I L.P. ("BMCO"), BlueMountain Strategic Credit Master Fund L.P. ("BMSC") and BlueMountain Montenvers Master Fund SCA SICAV-SIF ("BMM" and, together with BMCA, BMGP, BMCO and BMSC, the "Funds"), which are the direct beneficial owners of 1,442,716 shares of Common Stock in the aggregate. BMCM, although it directs the voting and disposition of the Common Stock held by the Funds, only receives an asset-based fee relating to the Common Stock held by the Funds.
F3On January 10, 2019, BMCA, BMGP, BMCO, BMSC and BMM sold 13,898, 3,106, 13,898, 5,200 and 13,898 shares of Common Stock, respectively, for $10.45 per share; 2,780, 621, 2,779, 1,040 and 2,780 shares of Common Stock, respectively, for $10.50 per share; 6,949, 1,553, 6,949, 2,600 and 6,949 shares of Common Stock, respectively, for $10.53 per share; 11,118, 2,485, 11,118, 4,160 and 11,119 shares of Common Stock, respectively, for $10.62 per share; 6,949, 1,554, 6,949, 2,600 and 6,948 shares of Common Stock, respectively, for $10.57 per share and 6,949, 1,554, 6,949, 2,600 and 6,948 shares of Common Stock, respectively, for $10.55 per share.
F4On January 11, 2019, BMCA, BMGP, BMCO, BMSC and BMM sold 16,677, 3,728, 16,678, 6,240 and 16,677 shares of Common Stock, respectively, for $10.61 per share and 5,559, 1,242, 5,559, 2,080 and 5,560 shares of Common Stock, respectively, for $10.60 per share.

Remarks

Elliot Mandelbaum, a former employee of BMCM, serves as a member of the board of directors of the Issuer as the representative of BMCM. In connection therewith, BMCM may be deemed to be a director by deputization of the Issuer solely for purposes of Section 16(a) of the Exchange Act. As a result, BMCM is listed a "Reporting Person" in Item 1 and the "Director" box is marked in Item 5 of this Form 4.